Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
about
Expression of High-Mobility Group Box 1 Protein (HMGB1) and Toll-Like Receptor 9 (TLR9) in Retinas of Diabetic RatsEffects of nuclear factor κB expression on retinal neovascularization and apoptosis in a diabetic retinopathy rat modelHMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.Thioredoxin plays a key role in retinal neuropathy prior to endothelial damage in diabetic mice.
P2860
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@ast
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@en
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@nl
type
label
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@ast
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@en
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@nl
prefLabel
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@ast
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@en
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@nl
P2093
P2860
P356
P1476
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
@en
P2093
Aniruddha Agarwal
Diana V Do
Quan Dong Nguyen
Yasir J Sepah
P2860
P304
P356
10.2147/PGPM.S52821
P407
P577
2014-01-01T00:00:00Z